Literature DB >> 25448948

Molecular structure, FT-IR, vibrational assignments, HOMO-LUMO analysis and molecular docking study of 1-[5-(4-Bromophenyl)-3-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone.

Y Sheena Mary1, C Yohannan Panicker2, M Sapnakumari3, B Narayana3, B K Sarojini4, Abdulaziz A Al-Saadi5, Christian Van Alsenoy6, Javeed Ahmad War7, H K Fun8.   

Abstract

The optimized molecular structure, vibrational frequencies, corresponding vibrational assignments of 1-[5-(4-bromophenyl)-3-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone have been investigated experimentally and theoretically using Gaussian09 software package. The title compound was optimized using the HF/6-31G(d) (6D, 7F), B3LYP/6-31G (6D, 7F) and B3LYP/6-311++G(d,p) (5D, 7F) calculations. The B3LYP/6-311++G(d,p) (5D, 7F) results and in agreement with experimental infrared bands. The geometrical parameters are in agreement with XRD data. The stability of the molecule arising from hyper-conjugative interaction and charge delocalization has been analyzed using NBO analysis. The HOMO and LUMO analysis is used to determine the charge transfer within the molecule. Molecular electrostatic potential was also performed. From the MEP it is evident that the negative charge covers the C=O group and the positive region is over the rings. First hyperpolarizability is calculated in order to find its role in nonlinear optics. Molecular docking studies suggest that the compound might exhibit inhibitory activity against TPII and may act as anti-neoplastic agent.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DFT; FT-IR; MEP; Molecular docking; Pyrazoline

Mesh:

Substances:

Year:  2014        PMID: 25448948     DOI: 10.1016/j.saa.2014.09.060

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  DFT and molecular docking investigations of oxicam derivatives.

Authors:  Y Shyma Mary; Y Sheena Mary; K S Resmi; Renjith Thomas
Journal:  Heliyon       Date:  2019-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.